Search Resources (English): Biotechnology

Results 11 - 20 of 37

Results

The real board of directors: the construction of biotechnology policy in Canada, 1980-2002

Describes who has actually been making the decisions about biotechnology, health policy, science policy, and much more for more than two decades.

Published: 2002
Health sector consultation document: renewal of the Canadian biotechnology strategy  
http://biotech.gc.ca/archives/engdoc/bh00157e.html

Addresses specific issues of the Canadian Biotechnology Strategy renewal pertaining to the health sector. Raises a number of consultation questions on which views are being sought within the areas of: health protection, health industries, and health sciences. (See Details)

Published: 1998
Does gender count?: Differences in English-Canadian beliefs, attitudes and behaviours towards breast cancer and infertility: des  
http://www.cewh-cesf.ca/PDF/nnewh/gender-count.pdf

Aims to provide an empirical framework for statements about Canadian attitudes towards, or use of, technologies and complementary care.

 (See Details)
Published: 2001
Environmental sustainability and the Canadian Biotechnology Strategy  
http://www.cwhn.ca/groups/biotech/availdocs/14-eichler.pdf
Takes the Canadian Biotechnology Strategy to tak for its claim to support sustainable development. Proposes a set of criteria for truly sustainable development, and evaluates the CBS in light of these criteria by focusing on the CBS's claims relating to agricultural biotechnology and bioengineered foods. Demonstrates that the risks of bioengineered foods are ignored by the CBS in its inflated listing of potential benefits. (See Details)
Published: 2000
The new genetics in the post-Keynesian state  
http://www.cwhn.ca/groups/biotech/availdocs/15-mykitiuk.pdf
Examines the Canadian Biotechnology Strategy and the genetic technologies it promotes to be both a contributor to, and signifer of, the changing nature of the state. (See Details)
Published: 2000
The new genetic therapies: the case of herceptin for breast cancer  
http://www.cwhn.ca/groups/biotech/availdocs/2-batt.pdf
Examines the challenge of genetics in relation to breast cancer. Introduces a new treatment protocol for breast cancer, herceptin or trastuzumab. Looks at its challenges, including its high price. (See Details)
Published: 2001
One part of an anti-racist feminist political standpoint against biopiracy  
http://www.cwhn.ca/groups/biotech/availdocs/16-sharma.pdf
Argues that the ethical values proposed by the Canadian Biotechnology Strategy are untenable, being premised on faith in the value of genetically engineered (GE) crops and foods. (See Details)
Published: 2000
Belling the cat: learning to know (but not necessarily trust) the new genetics  
http://www.cwhn.ca/groups/biotech/availdocs/3-kaufert.pdf
Examines the new genetics and its potential impact on women's health. (See Details)
Published: 2000
Nurturing cycles  
http://www.cwhn.ca/groups/biotech/availdocs/17-vanesterik.pdf
Looks at the inconsistencies between the promises made in the name of biotechnology and the lived experience of most of the world's women. (See Details)
Published: 2000
Ethics and genetics: the need for transparency  
http://www.cwhn.ca/groups/biotech/availdocs/4-brun-cox.pdf
Outlines research priorities which are intended as contributions to a strategy for building broader public debate. (See Details)
Published: 2000